The Light of Life Foundation, ThyCa: Thyroid Cancer Survivors’ Association, Inc., and Eisai Inc. today announced the launch of Myths and Truths About Thyroid Cancer, an interactive, educational campaign designed to help dispel the myth that thyroid cancer is a “good cancer.” Because most thyroid cancers can be successfully treated, many are told if you are going to get cancer, thyroid cancer is the one to have, which has led to this misperception. However, whether successfully treated or not, the truth is all cancers can have a significant impact on a person’s life, beginning with the shock and distress of hearing the word “cancer” at diagnosis. In honor of Thyroid Cancer Awareness Month and the tens of thousands who receive a thyroid cancer diagnosis each year, Myths and Truths About Thyroid Cancer illustrates the life-changing realities of this disease.
“As a thyroid cancer survivor, I urge people to stop referring to thyroid cancer as the ‘good cancer,’ as I believe it downplays patients’ experiences,” said Joan Shey, founder of the Light of Life Foundation. “I hear time and time again from patients how difficult their diagnosis and treatment were and that their scars are more than skin deep. My hope is that this campaign can educate about the many types of thyroid cancer and change the thyroid cancer conversation.”
“Being part of a community of survivors is very important for people coping with thyroid cancer,” said Gary Bloom, thyroid cancer survivor and co-founder and executive director of ThyCa: Thyroid Cancer Survivors’ Association. “ThyCa takes this to heart, which is why we are proud to provide support and resources to the thyroid cancer community. We also know more needs to be done to elevate awareness of thyroid cancer and what patients need in terms of support for the rest of our lives.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7595951-eisai-thyroid-cancer-myths/
Music To Save Lives - Malaria No More UK. Music is incredibly emotive, but now, thanks to Malaria No More UK, it has the power to save lives. Over 780,000 people, the equivalent of the UK's 12 largest music festivals, die each year from malaria.
Malaria No More UK are using the power of music to raise awareness about this devastating, yet preventable and treatable disease. They want to inspire action and are giving you the chance to win a pair of tickets to the:
The Big Chill
Parklife Weekend
Wychwood Festival
Sonisphere
http://malarianomore.org.uk/festivals
http://www.miraclemulti.com MiracleMulti™ The Best Multivitamins on the market for Men, Women, Vegetarians, and Bodybuilding. Once a day Multivitamin for Health, Energy, Focus, Well Being and Anti-aging.***These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Fusion-io and two-time USA Memory Champion Nelson Dellis are teaming up to showcase the importance of memory in our minds and our datacenters. While Fusion-io focuses on helping its customers scale the challenges in their datacenters, Nelson will be focused on scaling the challenges he will face on Mount Everest, including what happens to your memory under the extreme conditions found on the world's highest mountain.
To view Multimedia News Release, go to http://www.multivu.com/players/English/60918-fusion-io-climb-for-memory
Hi, Rudy here, to tell you how to protect your eyes from disease. First, let’s start with Krill Oil.
Neptune Krill Oil is now at the top of the list for omega 3 oil since it is found in Antarctica where there is little or no pollution. Krill oil has less dangerous levels of mercury and lead. It also has phospholipids that fish oil does not have, which helps to build your cell membranes.
Eye diseases like cataract, glaucoma, detached retina, or myopia all come from weakness and inflammation in the tissues that compose and surround the eye. Most doctors don’t know what to say to you on how you can strengthen and protect your eyes from becoming disease or if you have an eye disease on how to improve your condition
Crosstex International, a subsidiary of Cantel Medical Corp. (NYSE:CMN), and Prestige Ameritech, the only two major U.S.-based medical mask manufacturers have joined forces to bring attention to a glaring void in public health research and policy – that, if addressed, has the potential to more quickly provide a simple, effective tool to mitigate the spread of influenza and other respiratory borne viruses. The awareness campaign comes in response to a new study, “ Exposure to Influenza Virus Aerosols During Routine Patient Care,” published in The Journal of Infectious Diseases, showing that influenza viruses may spread as far as six feet from a person coughing or sneezing, and that some people, referred to as “super spreaders,” may be more likely to spread the virus. The study, supported by the Department of Health and Human Services with a $600,000 research grant, pointed specifically to concerns for healthcare workers being exposed to coughs from sick patients. Yet government research and policy continues to overlook face masks as a feasible protection measure for both the healthcare industry and the general public.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60417-cantel-medical-fitted-mask-infectious-disease-control-public-health-policy
Every 23 seconds, someone in the United States is diagnosed with diabetes. It's estimated that one in 11 Americans has the disease—more than 29 million people—and another 86 million have prediabetes and are at risk for developing type 2 diabetes. The numbers alone are staggering, and the people affected by the disease include those who have diabetes and their friends, family, caregivers and communities.
American Diabetes Month®, observed by the American Diabetes Association® (Association) every November, is a time to focus the nation's attention on the many people who are affected by diabetes and to raise the urgency about the need to address diabetes. To help spark a national conversation, the Association is asking people to share their stories about what it truly means to live with diabetes with a new campaign, This Is Diabetes™.
http://www.multivu.com/players/English/7711431-american-diabetes-month-thisisdiabetes/
Mimi’s Cafe Goes Red. Starting in February, American Heart Month, Mimi’s Cafe is giving a piece of its heart to the American Heart Association’s Go Red For Women movement. The neighborhood bistro inspired by France is the first-ever restaurant to nationally support the effort. Go Red For Women is dedicated to fighting heart disease, the number one killer of women, and harnessing the energy, passion and power women have to band together and collectively wipe out the disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54331-mimi-s-cafe-american-heart-association-go-red-for-women-heart-month
Mimi’s Cafe is raising awareness throughout February, American Heart Month, by supporting the American Heart Association’s® Go Red For Women® movement and its mission to turn America red. Mimi’s was the first restaurant to support Go Red For Women on a national scale. In its second year, Mimi’s will shout louder and stand stronger in the fight against heart disease, the number one killer of women, with its Mimi’s Goes Red campaign.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60186-mimi-s-cafe-go-red-for-women-put-your-hearts-up
The Oral Cancer Foundation is pleased to have developed partnerships with two highly visible Hollywood stars to raise awareness of a disease of which too few people in the U.S. have ever heard. Academy Award winning actor, Michael Douglas, who has recently completed successful treatment for an advanced oral cancer, and Emmy and Tony Award winning actress, Blythe Danner, who lost her husband to the same disease have partnered with OCF to send a very important message about screening and early detection of oral cancer to the American public.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57170-oral-cancer-foundation-michael-douglas-early-detection-psa-campaign
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease.
With this FDA approval, Boston Scientific will commence commercialization of the first and only BP-DES in the U.S. Notably, both the drug coating and the polymer – which modulates drug release – are fully absorbed shortly after drug elution is complete at three months.
The SYNERGY Stent provides synchronized drug and polymer absorption. It is designed to enable more rapid and complete arterial healing, and to thereby reduce the risk of complications associated with long-term polymer exposure compared to currently-used drug-eluting stents (DES) with permanent polymers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7223456-boston-scientific-fda-approval-synergy/
